ACKERMAN, Z., M. ORON-HERMAN, M. GROZOVSKI, T. ROSENTHAL, O. PAPPO, G. LINK u. B. A.
SELA (2005):
Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.
Hypertension 45, 1012-1018.
ADACHI, M. u. D. A. BRENNER (2008):
High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase.
Hepatology 47, 677-685.
ALCANTARA, V. M., E. A. CHAUTARD-FREIRE-MAIA, M. SCARTEZINI, M. S. CERCI, K. BRAUN-PRADO u. G. PICHETH (2002):
Butyrylcholinesterase activity ans risk factors for coronary artery disease.
Scand. J. Clin. Lab. Invest. 62, 399-404.
ALCANTARA, V. M., L. C. OLIVEIRA, R. R. RÉA, H. L. SUPLICY u. E. A. CHAUTARD-FREIRE-MAIA (2003):
Butyrylcholinesterase and obesity in individuals with the CHE2C5+ and CHE2C5-phenotypes.
Int. J. Obes. Relat. Metab. Disord. 27, 1557-1564.
ALI, S. u. S. ALI (2007):
Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
Gene 401, 38-45.
ALVAREZ ARROYO, M. V., M. A. CASTILLA, F. R. GONZALÉZ PACHECO, D. TAN, A. RIESCO, S.
CASADO u. C. CARAMELO (1998):
Role of vascular endothelial growth factor on erythropoietin-related entdothelial cell proliferation.
J. Am. Soc. Nephrol. 9, 1998-2004.
AMARAPURKAR, A. D., D. N. AMARAPURKAR, S. VIBHAV u. N. D. PATEL (2007):
Angiogenesis in chronic liver disease.
Ann. Hepatol. 6, 170-183.
ANANIA, F. A. (2005):
Adiponectin and alcoholic fatty liver: Is it, after all, about what you eat?
Hepatology 42, 530-532.
LITERATURVERZEICHNIS
ARANETA, M. R.. u. E. BARRETT-CONNOR (2007):
Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American and white women.
Obesity (Silver Spring) 15, 2454-2462.
ARORA, A. u. S. ARORA (2008):
Leptin and its metabolic interactions: an update.
Diabetes Obes. Metab. 10, 973-93.
ARUN, J., R. H. CLEMENTS, A. J. LANZENBY , R. R. LEETH u. G. A. ABRAMS (2006):
The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to woman.
Obes. Surg. 16, 1351-1358.
BARDIN, C. W. u. J. F. CATTERALL (1981):
Testosterone: a major determinant of extragenital sexual dimorphism.
Science 211, 1285-1294.
BATRA, A., M. ZEITZ u. B. SIEGMUND (2005):
Die Stellung von Leptin im Immunsystem – Verbindung von Endokrinologie und Immunologie.
Dtsch. Med. Wochenschr. 130, 226-229.
BELLENTANI, S., G. BEDOGNI, L. MIGLIOLI L u. C. TIRIBELLI (2004):
The epidemiology of fatty liver.
Eur. J. Gastroenterol. Hepatol. 16, 1087-1093.
BLECHACZ, B. u. W. STREMMEL (2003):
NASH – Nicht-alkoholische Steatohepatitis.
Z. Gastroenterol. 41, 77-90.
BLUMBERG, B. S., A. I. SUTNICK, W. T. LONDON u. L. MELARTIN (1972):
Sex distribution of Australia antigen.
Arch. Intern. Med. 130, 227-231.
BÖCK, P. (Hrsg.) (1989):
Romeis-Mikroskopische Technik.
17. Auflage, Verlag Urban und Schwarzenberg, München – Wien –Baltimore .
LITERATURVERZEICHNIS
BRAY, G. A. u. D. A. YORK (1972):
Studies on food intake of genetically obese rats.
Am. J. Physiol. 223, 176-179.
CALDWELL, S. H., D. M. CRESPO, H. S. KANG u. A. M. AL-OSAIMI (2004):
Obesity and hepatocellular carcinoma.
Gastroenterology 127, S97-103.
CALLE, E.E. u. R. KAAKS (2004):
Overweight, obesity and cancer: epidemiological evidence and proposed mechanism..
Nat. Rev. Cancer 4, 579-591
CARDENAS, G.A., C. J. LAVIE, V. CARDENAS, R.V. MILANI u. P. A. MCCULLOUGH (2008):
The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Rev. Cardiovasc. Med. 9, 239-258.
CASATI, A. u. M. PUTZU (2005):
Anesthesia in obese patient: pharmacokinetic considerations.
J. Clin. Anesth. 17, 134-145.
CASSIMANN, D. u. J. JAEKEN (2008):
Nash may be trash.
Gut 57, 141-144.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (2008):
http://www.criver.com/SiteCollectionDocuments/Lewis%20Rat.pdf http://www.criver.com/SiteCollectionDocuments/CD-RAT23.04.07.pdf http://www.criver.com/SiteCollectionDocuments/Wistar%20rat.pdf Hauptseite: http://www.criver.com/fr-FR/Pages/home.aspx
CHATAMRA, K., P. M. DANIEL u. D. K. LAM (1984):
The effects of fasting on core temperature, blood glucose and body and organ weights in rats.
Q. J. Exp. Physiol. 69, 541-545.
LITERATURVERZEICHNIS
CHITTURI, S., G. C. FARELL, E. HASHIMOTO, T. SAIBARA, G. K. LAU u. J. D. SOLLANO (2007):
The Asia-pacific Working Party on NAFLD. Non alcoholic fatty liver disease in the Asia-Pacific region:
definitions and overview of proposed guidelines.
J. Gastroenterol. Hepatol. 22, 778-787.
CLUTTON, R. E. (1988):
The medical implications of canine obesity and their relevance to anaesthesia.
Br. Vet. J. 144, 21-28.
CODES, L., L. MATOS u. R. PARANÁ (2007):
Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits.
Braz. J. Infect. Dis. 11, 371-374.
CRAMPE, H. (1877):
Kreuzungen zwischen Wanderratten verschiedener Farbe.
Landwirtsch. Jahrb. 6, 385-395.
CRAMPE, H. (1883):
Zuchtversuche mit zahmen Wanderratten. I. Resultate der Zucht in Verwandtschaft.
Landwirtsch. Jahrb. 12, 389-449.
CRAMPE, H. (1884):
Zuchtversuche mit zahmen Wanderratten. I. Resultate der Kreuzung der zahmen Ratten mit Wilden.
Landwirtsch. Jahrb. 13, 699-754.
CRAMPE, H. (1885):
Die Gesetze der Beerbung der Farbe.
Landwirtsch. Jahrb. 14, 539-619.
CROWLEY, H., W. D. LEWIS, F. GORDON, R. JENKINS u. U. KHETTRY (2000):
Steatosis in donor and transplant liver biopsies.
Hum. Pathol. 31, 1209-1213.
DANCYGIER, H. (2006):
Pathogenese und Therapie der nicht-alkoholischen Fettlebererkrankungen: Von der Fettleber zur Zirrhose.
Dtsch. Arztebl. 2006; 103, A 1301-1307.
LITERATURVERZEICHNIS
DEGAWA-YAMAUCHI, M., J. R. DILTS, J. E. BOVENKERK, C. SAHA, J. H. PRATT u. R. V. CONSIDINE (2003):
Lower serum adiponectin levels in African-American boys.
Obes. Res. 11, 1384-1390.
DELZENNE, N. M., N. A. HERNAUX u. H. S. TAPER (1997):
A new model of acute liver steatosis induced in rats by fasting and refeeding a high carbohydrate-fat free diet.
Biochemical and morphological analysis.
J. Hepatol. 26, 880-885.
DONTHAMSETTY, S. , V. S. BHAVE, M. S. MITRA, J. R. LATENDRESSE u. H. M. MEHENDALE (2007):
Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxity.
Hepatology 45, 391-403.
FARRELL, G. C. (2003):
Non-alcoholic steatohepatitis: What is it, and why is it imporrtant in the Asia-Pacific region.
J. Gastroenterol. Hepatol. 18, 124-138.
FARRELL, G. C. u. C. Z. LARTER (2006):
Nonalcoholic fatty liver disease: from steaotis to cirrhosis.
Hepatology 43, S99-S112.
FERRÉ, P. u. F. FOUFELLE (2007):
SREBP-1c transcription factor and lipid homeostasis: clinical perspective.
Horm. Res. 68, 72-82.
FLEGAL, K. M., M. D. CARROLL, C. L. OGDEN u. C. L. JOHNSON (2002):
Prevalence and trends in obesity among US adults, 1999-2000.
JAMA 288, 1772-1773.
FROSSARD, J. L., M. L. STEER u. C. M. PASTOR (2008):
Acute pancreatitis.
Lancet 371, 143-152.
FRÜHBECK G. (2006):
Intracellular signalling pathways activated by leptin.
Biochem. J 393, 7-20.
LITERATURVERZEICHNIS
GAO Q. u. T. L. HORVATH (2008):
Cross-talk between estrogen and leptin signaling in the hypothalamus.
Am. J. Physiol. Endocrinol. Metab. 294, E817-826.
GARTEL, A. L. u. S. K. RADHAKRISHNAN (2005):
Lost in transcription: p21 repression, mechanism and consequences.
Cancer Res. 65, 3980-3985.
GERMAN, A. J. (2006):
The growing problem of obesity in dogs and cats.
J. Nutr. 136, 1940S-1946S.
GLUCKSMANN, A. (1974):
Sexual dimorphism in mammals.
Biol. Rev. Camb. Philos. Soc. 49, 423-475
GOSSELLIN, J., J. A. WREN u. S. J. SUNDERLAND (2007):
Canine obesity: an overview.
J. Vet. Pharmacol. Ther. 30 Suppl 1:1-10.
HARADA, H., K. P. PAVLICK, I. N. HINES, D. J. LEFER, J. M. HOFFMAN, S. BHARWANI, R. E. WOLF u. M. B. GRISHAM (2003):
Sexual dimorphism in reduced-size liver ischemia and reperfusion injury in mice: role of endothelial cell nitric oxide synthase.
Proc. Natl. Acad. Sci. U.S.A. 100, 739-744.
HEROLD, G. (Hrsg.) (2005):
Innere Medizin.
Dr. Gerd Herold-Verlag, Köln.
HOFSTETTER, J, M. A, SUCKOW u. D. L. HICKMANN (2006):
Morphophysiology.
in: M. A. SUCKOW, S. H. WEISBROTH u. C. L. FRANKLIN (Hrsg.):
The laboratory rat. Second edition.
Elsevier Academic Press, Burlington, San Diego, S. 94
LITERATURVERZEICHNIS
HULVER, M. W., O. SALEH, K. G: MACDONALD, W. J. PORIES u. H. A. BARAKAT (2004):
Ethnic differences in adiponectin levels.
Metabolism 53, 1-3.
IIDA, M., T. MURAKAMI, K. ISHIDA, A. MIZUNO, M. KUWAJIMA u. K. SHIMA (1996):
Substitution at codon 269 (glutamine --> proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat.
Biochem. Biophys. Res. Commun. 224, 597-604.
IONESCU, E., J. F. SAUTER u. B. JEANRENAUD (1985):
Abnormal oral glucose tolerance in genetically obese (fa/fa) rats.
Am. J. Physiol. 248, E500-506.
JANSSON, J. O., S. EDÉN u. O. ISAKSSON (1985):
Sexual dimorphism in the control of growth hormone secretion.
Endocr. Rev. 6, 128-150.
JIANG, L. L., L. LI, X. F. HONG, Y. M. LI u. B. L. ZHANG (2009):
Patients with non-alcoholic fatty liver disease diplay increased serum resistin levels and decreased Adiponectin levels.
Eur. J. Gastroenterol. Hepatol. 2009 Mar 11. [Epub ahead of print]
KADOWAKI, T., T. YAMAUCHI, N. KUBOTA, K. HARADA, K. UEKI u. K. TOBE (2006):
Adiponectin and Adiponectin receptors in insulin resistence, diabetes, and the metabolic syndrome.
J. Clin. Invest. 116, 1784-1792.
KALRA, M., J. MAYES, S. ASSEFA, A. K. KAUL u. R. KAUL (2008):
Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.
World J Gastroenterol. 14, 5945-5961.
KASHIREDDY, P. R. u. M. S. RAO (2004)
Sex differences in choline-deficient diet-induced steatohepatitis in mice.
Exp. Biol. Med. 229;158-162.
KAWANO, J. u. R. ARORA (2009):
The role of adiponectin in obesity, diabetes and cardiovascular disease.
J. Cardiomet. Syndr. 4, 44-49.
LITERATURVERZEICHNIS
KARAMYSHEVA, A. F. (2008):
Mechanism of angiogenesis.
Biochemistry (Mosc). 73, 751-762.
KIENZLE, E., R. BERGLER u. A. MANDERNACH (1998):
A comparison of the feeding behaviour and the human-animal relationship in owners of normal and obese dogs.
J. Nutr. 128, 2779S-278S.
KIRSCH, R., V. CLARKSON, E. G. SHEPHARD, D. A. MARAIS, M. A. JAFFER, V. E. WOODBURNE, R.
E. KIRSCH u. P. DE L HALL (2003):
Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies.
J. Gastroenterol. Hepatol. 18, 1272-1282.
KISSELEVA, T. u. D. A. BRENNER (2007):
Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis J. Gastroenterol. Hepatol. 22, S73-78.
KLEINER, D.E., E. M. BRUNT, M. VAN NATTA, C. BEHLING, M. J. CONTOS, O. W. CUMMINGS, L. D.
FERRELL, Y. C. LIU, M. S. TORBENSON, A. UNALP-ARIDA, M. YEH, A. J. MCCULLOUGH, A. J.
SANYAL u. NONALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK (2005):
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
Hepatology 41, 1313-21.
KLUWE, J. u. A. W. LOHSE (2005):
Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis Internist (Berl) 46, 1324-30.
KOPELMAN, P. G. (2000):
Obesity as a medical problem.
Nature 404, 635-43
KOTEISH, A. u. A. M. DIEHL (2002):
Animal models of steatohepatitis.
Best. Pract. Res. Clin. Gastroenterol. 16, 679-690.
LALL, C. G., A. M. AISEN, N. BANSAL u. K. SANDRASEGARAN (2008):
LITERATURVERZEICHNIS
LARTER, C. Z. u. M. M. YEH (2008):
Animal models of NASH: getting both pathology and metabolic context right.
J Gastroenterol Hepatol 23, 1635-1648.
LECLERCQ, I. A. (2007)
Pathogenesis of steatohepatitis: insights from the study of animal models.
Acta Gastroenterol. Belg. 70, 25-31.
LECLERCQ, I. A., G. C. FARRELL, R. SCHRIEMER u. G. R. ROBERTSON (2002):
Leptin is essential for the hepatic fibrogenic response to chronic liver injury.
J Hepatol 37, 206-213.
LIEBER, C. S., M. A. LEO, K. M. MAK, Y. XU, Q. CAO, C. REN, A. POMARENKO u. L. M. DECARLI (2004):
Model of nonalcoholic steatohepatitis.
Am. J. Clin. Nutr. 79, 502-509.
LINDSEY, J. R. u. H. J. BAKER (2006):
Historical Foundations.
in: M. A. SUCKOW, S. H. WEISBROTH u. C. L. FRANKLIN (Hrsg.):
The laboratory rat. Second edition.
Elsevier Academic Press, Burlington, San Diego, S. 1-53.
LODATO, F., G. MAZELLA, D. FESTI, F. AZZAROLI, A. COLECCHIA u. E. RODA (2006):
Hepatocellular carcinoma prevention: A worldwiede emergence between opulence of developed countries an the economic constaints of developing countries.
World J. Gastroenterol. 12, 7239-7249.
LONARDO, A., M. BELLINI, P. TARTONI u. E. TONDELLI (1997):
The bright liver syndrome. Prevalence and determinants of a “bright” liver echo pattern.
Ital. J. Gastroenterol. Hepatol. 29, 351-356.
LONARDO, A., C. CARANI, N. CARULLI N u. P. LORIA (2006):
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.
J. Hepatol. 44, 1196-1207.
LITERATURVERZEICHNIS
LUDWIG, J., T. VIGGIANO, D. MCGILL u. B. OTT (1980):
Nonalcoholic steatohepatitis. Mayo clinic experience with a hitherto unnamed disease.
Mayo Clin. Proc. 55, 434-438.
MCCORMACK, L., H. PETROWSKY, W. JOCHUM, K. FURRER u. P. A. CLAVIEN (2007):
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study.
Ann. Surg. 245, 923-930.
MCCULLOUGH, A. J. (2006):
Pathophysiology of non-alcoholic steatohepatitis.
J. Clin. Gastroenterol. 40, S17-29.
MUIR, A.J., J. D. BORNSTEIN, P. G. KILLENBERG u. ATLANTIC COAST HEPATITIS TREATMENT GROUP (2004):
Peginterferon alfa-2b and ribavirin for the treatment if chronic hepatitis C in blacks ans non-Hispanic whites.
N. Engl. J. Med. 350, 2265-2271.
MULET, T., C. PICÓ, P. OLIVER u. A. PALOU (2003):
Blood leptin homeostasis: sex.associated differences in circulating leptin levels in rats are independent of tissue leptin expression.
Int. J. Biochem. Cell Biol. 35, 104-110.
NANJII, A. A. (2004 a):
Animal models of nonalcoholic fatty liver disease and steatohepatitis.
Clin. Liver Dis. 8, 559-574.
NANJII, A. A. (2004 b):
Another animal model for nonalcoholic steatohepatitis: how close to the human condition?
Am. J. Clin. Nutr. 79, 350-351.
NAGOSHI, S. (2008):
Sex- or gender-specific medicine in hepatology.
Hepatol. Res. 38, 219-24.
LITERATURVERZEICHNIS
NAR, A. u. O. GEDIK (2008):
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease.
Acta Diabetol. 46, 113-118..
NEMOTO, Y., K. TODA, M. ONO, K. FUJIKAWA-ADACHI, T. SAIBARA, S. ONISHI, H. ENZAN, T.
OKADA u. Y SHIZUTA (2000):
Altered expression of fatty acis-metabolizing enzymes in aromatase-deficient mice.
J. Clin. Invest. 105, 1819-25.
NISHIDA, M., T FUNAHASHI u. I. SHIMIMURA (2007):
Pathophysiological significance of adiponectin.
Med. Mol. Morphol. 40, 55-67.
NISHIZAWA, H., I SHIMOMURA, K. KISHIDA, N. MAEDA, H. KURIYAMA, H. NAGARETANI, M.
MATSUDA, H. KONDO, N. FURUYAMA, S. KIHARA, T. NAKAMURA, Y. TOCHINO, T. FUNAHASHI u.
Y. MATSUZAWA (2002):
Androgenes decrease plasma Adiponectin, an insulin-sensitizing adipocyte derived protein.
Diabetes 51, 2734-2741.
PAGANO, C., G. SOARDO, W. ESPOSITO, F. Fallo, L. BASAN, D. DONNINI, G. FEDERSPIL, L. A. SECHI u. R. VETTOR (2005):
Plasma adiponectin is decreased in non-alcoholic fatty liver disease.
Eur. J. Endocrinol. 152, 113-118.
PANTSARI, M.W. u. S. A. HARRISON (2006):
Nonalcoholic fatty liver disease presenteing with an isolated elevated alkaline phosphatase.
J. Clin. Gastroenterol. 40, 633-635.
PERKINS, J. D. (2006):
Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.
Liver Transplant. 12, 1012-1013.
PHILIPEAUX, J. M. (1856):
Note sur l´extirpation des capsules survenales chez les rats albinos (Mus rattus).
C. R. Habd. Seances Acad. Sci. 43, 904-906.
LITERATURVERZEICHNIS
PHILLIPS, M. S., Q. LIU, H. A. HAMMOND, V. DUGAN, P. J. HEY u. C. J. CASKEY (1996) : Leptin receptor missense mutation in the fatty Zucker rat.
Nat. Genet. 13, 18-19.
PICARD, C., L. LAMBOTTE, P. STARKEL, C. SEMPOUX, A. SALIEZ, V. VAN DEN BERGE u. Y.
HORSMANS Y.(2002) :
Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats.
J. Hepatol. 36, 645-52.
PRIEGO, T., J. SÁNCHEZ, C. PICÓ u. A. PALOU (2008):
Sex-differential expression of metabolism-related genes in response to a high-fat-diet.
Obesity (Silver Spring) 16, 819-826.
PRIEGO, T., J. SANCHÉZ, C. PICÓ u. A. PALOU (2009):
Sex-associated difference in the leptin and ghrelin systems related with the induction of hyperphagia under high-fat diet exposure in rats.
Horm. Behav. 55, 33-40.
QIAN, Y., J. G. FAN (2005):
Obesity, fatty liver and liver cancer.
Hepatobilliary Pancreat. Dis. Int. 4, 173-177.
RANDELL, E. W., M. S. MATHEWS, H. ZHANG, J. S. SERAJ u. G. SUN (2005):
Relationship netween serum butyrylcholinesterase and the metabolic syndrome.
Clin. Biochem. 38, 799-805.
RAVUSSIN, E., M. E. ALENCIA., J. ESPARZA, P. H. BENNETT u. L. O. SCHULZ (1994):
Effects of traditional lifestyle on obesity in Pima Indians.
Diabetes Care 17, 1067-74.
REDAELLI, C. A., D. SEMALA, F. E. CARRICK, M. LEDERMANN, D. CANDINAS, B. SAUTER u. J. F.
DUFOUR (2004):
Effect of vascularendothelial growth factor on functional recovery after hepatectomy in lean and obese mice.
J. Hepatol. 40, 305-312.
REID, A. E. (2001):
LITERATURVERZEICHNIS
RENALDI, O., B. PRAMONO, H. SINORITA, L. B. PURNOMO, R. H. ASDIE u. A. H. ASDIE (2009):
Hypoadiponectinemia: a risk factor for metabolic syndrome.
Acta Med. Indones. 41, 20-24.
RIBOT, J., A. M. RODRIGUEZ, E. RODRIDUEZ u. A. PALOU (2008):
Adiponectin and resistin response in the onset of obesity in male and female rats.
Obesity (Silver Spring) 16, 723-730.
RINELLA, M. E. u. R. M. GREEN (2004):
The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance.
J. Hepatol. 40, 47-51.
SALLMANN, H. P. u. H. FUHRMANN (2000):
in: VON ENGELHARDT, W. u. G. BREVES:
Physiologie der Haustiere.
Enke im Hippokrates-Verlag, Stuttgart.
SANDBERG, R., R. YASUDA, D. G. PANKRATZ, T: A: CARTER, J. A. DEL RIO, L. WODICKA, M.
MAYFORD, D. J. LOCKHART u. C. BARLOW (2000):
Regional and strain specific gene expression mapping in the adult mouse brain.
Proc. Natl. Acad. Sci. USA 97, 11038-11043.
SANYAL, A. J. (2002):
AGA technical review on nonalcoholic fatty liver disease.
Gastroenterology 123, 1705-1725.
SARTORIO, A., A. DEL COL, G. MAZZILLI, S. BELENTANI, C: TIRIBELLI u. G. BEDOGNI (2007):
Predictors of non-alcoholic fatty liver disease in obese children.
Eur. J. Clin. Nutr. 61 877-883.
SELZNER, N., M. SELZNER, W. JOCHUM, B. AMANN-VESTI, R. GRAF u. P. A. CLAVIEN (2006):
Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.
J. Hepatol. 44, 694-701.
SEIDEL, S. D., S.C. HUNG, H. L. KAN u. B. B. GOLLAPUDI (2006):
Background gene expression in rat kidney: influence of strain, gender and diet.
LITERATURVERZEICHNIS
SHIBUYA, M. (2006):
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
J. Biochem. Mol. Biol. 39, 469-478.
SMEDILE, A. u. E. BUGIANESI (2005):
Steatosis and hepatocellular carcinoma risk.
Eur. Rev. Med. Pharmacol. Sci. 9, 291-293.
TESLIGTE, K., I. BOURASS, J. P. SELS, A. DRIESSEN, R. W. STOCKBRÜGGER u. G. H. KOEK (2004):
Non-alcoholic steatohepatitis: review of a growing medical problem.
Eur. J. Int. Med. 15, 10-21.
TOTH, P. P. (2008)
When high is low: raising low levels of high-density lipoprotein cholesterol.
Curr. Cardiol. Rep. 10, 488-496.
UYGUN, A., A. KADAYIFCI, Z. YESILOVA, A. ERDIL, H. YAMAN, M. SAKA, M. S. DEVICI, S. BAGCI, M. GULSEN, N. KARAEREN u. K. DAGALP (2000):
Serum leptin levels in patients with non-alcoholic steatohepatitis.
Am. J. Gastroenterol. 95, 3584-3589.
VELASQUEZ, M. T. u. S. J. BHATHENA (2007):
Role of dietary soy protein in obesity.
Int. J. Med. Sci. 4, 72-82.
VETELÄINEN, R., A. VAN VLIET u. T. M. VAN GULIK (2007 a):
Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
J. Gastroenterol .Hepatol. 22, 1526-33.
VETELÄINEN, R., R. J. BENNINK, A. K. VAN VLIET u. T. M. VAN GULIK (2007 b):
Mild steaotsis impairs functional recovery after liver resection in an experimental model.
Br. J. Surg. 94, 1002-1008.
VUPPALANCHI, R., S. MARRI, D. KOLWANKAR, R. V. CONSIDINE u. N. CHALASANI (2005):
Is Adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.
LITERATURVERZEICHNIS
WALKER, J. R., A. I. SU, D. W. SELF, J. B. HOGENESCH, H. LAPP, R. MAIER, D. HOYER u. G. BILBE (2004):
Applications of a rat multiple tissue gene expression data set.
Genome Res. 14, 742-749.
WANG, J., H. LI, O. H. FRANCO, Z. YU, Y. LIU u. X LIN (2008):
Adiponectin and metabolic syndrome in middle-aged and elderly Chinese.
Obesity (Silver Spring) 16, 172-178.
WANLESS, I. R. u. J. S. LENTZ (1990):
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Hepatology 12, 1106-1110.
WESTON, S. R., W. LEYDEN, R. MURPHY, N. M. BASS, B. P. BELL, M. M. MANOS u. N. TERRAULT (2005):
Racial and Ethnic distribution of Nonalcoholic Fatty Liver in Persons With Newly Diagnosed Chronic Liver Disease.
Hepatology 41, 372-9.
WHITEHEAD, J. R., A. A. RICHARDS, I. J. HICKMAN, G. A MACDONALD u. J. B. PRINS (2006):
Adiponectin – a key adipokine in the metabolic syndrome.
Diabetes Obes. Metab. 8, 264-80.
WILLETT, W. C., W. H. DIETZ u. G. A. COLDITZ (1999):
Guidelines for healthy weight.
N. Engl. J. Med. 341, 427-434.
XU, A., Y. WANG, H. KESHAW, L. Y. XU, K. S. LAM u. G. J. COOPER (2003):
The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver disease in mice.
J. Clin. Invest. 112, 91-100.
YAMAZAKI, Y., S. KAKIZAKI, D. TAKIZAWA, T. ICHIKAWA, K. SATO, H. TAKAGI u. M. J. MORI (2008):
Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
J. Gastroenterol. Hepatol. 23, 276-82.
LITERATURVERZEICHNIS
YANCOPOULOS, G. D., S. DAVIS, N. W. GALE, J: S: RUDGE, S.J. WIEGAND u. J. HOLASH (2000):
Vascular-specific growth factors and blood vessel formation.
Nature 407, 242-248.
ZHANG, F., M. B. BASINSKI, J. M. BEALS, S. L. BRIGGS, L. M. CHURGAY, D. K. CLAWSON , R. D.
DIMARCHI, T. C. FURMAN, J. E. HALE, H. M. HSIUNG, B. E. SCHONER, D. P. SMITH, X. Y. ZHANG, J.
P. WERY u. R. W. SCHEVITZ (1997):
Crystal structure of the obese protein leptin-E100.
Nature 387, 206-209.
ZIMMET, P., K. G. ALBERTI u. J. SHAW J (2001):
Global and societal implications of the diabetes epidemic.
Nature 414, 782-787.
ZOU, Y., J. LI, C. LU, J. WANG, J. GE, Y. HUANG, I. ZHANG u. Y. WANG (2006):
High-fat emulsion-induced rat model of non-alcoholic steatohepatitis.
Life Sci. 79, 1100-1107.
ZUCKER, L. M. u. T. F. ZUCKER (1961):
Fatty, a new mutation in the rat.
J. Hered. 52, 275-278.
ZUR, B. (2005):
Laborchemische Referenzbereiche für Wistarratten und C57BL/6-Mäuse.
Düsseldorf, Heinrich-Heine-Universität, Med. Fakultät, Diss.
ANHANG